Skip to main content
All inhalers

DULERA

Mometasone/Formoterol

DULERA

ICSLABA MDI

Mometasone furoate / Formoterol fumarate dihydrate · Organon

Clinical Reference

Active Medication & Mechanism

  • Mometasone furoate ICS
    100 mcg or 200 mcg per actuation

    Synthetic corticosteroid with potent anti-inflammatory activity. Reduces airway inflammation by inhibiting multiple inflammatory cell types and cytokine release.

  • Formoterol fumarate dihydrate LABA
    5 mcg per actuation

    Long-acting beta2-adrenergic agonist with rapid onset. Relaxes airway smooth muscle through beta2-receptor stimulation and increased cAMP.

FDA-Approved Dosing by Indication

// approval varies by strength + age
Asthma
2/3 approved regimens
  • 100/5 mcg FDA Approved
    Pop · Patients ≥12 years
    2 inhalations twice daily (morning and evening)
    For patients previously on medium-dose ICS.
    Total · 400/20 mcg
  • 200/5 mcg FDA Approved
    Pop · Patients ≥12 years
    2 inhalations twice daily
    For patients previously on high-dose ICS. Maximum recommended dose.
    Total · 800/20 mcg
  • Any strength Not Approved
    Pop · Acute bronchospasm
    Total · Not a rescue inhaler. Use a SABA for acute symptoms.
COPD
0/1 approved regimens
  • Any strength Not Approved
    Pop · Adults
    Total · Dulera is not indicated for COPD.
Acute Use
0/1 approved regimens
  • Any strength Not Approved
    Pop · Acute bronchospasm / rescue
    Total · Not for acute relief. Use a SABA.

For clinical reference only. This workspace is intended for use by qualified healthcare professionals and is not a substitute for clinical judgement, prescribing information, or product monographs. Always verify doses and indications against the most current labelling before prescribing.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved